Top news of the week: 20.10.2021.
Companies And Industries
Next generation prime editing systems move closer to possible therapeutic applications
Researchers have boosted the efficiency of prime editing, a highly versatile CRISPR-based gene editing technology, and used the improved system to correct disease mutations in cells.
New Biotech Company Emerges to Tackle Multifunctional Biotherapeutics
On Thursday, Tentarix Biotherapeutics announced that it earned $50 million in a Series A financing round, which was co-led by Versant Ventures and Samsara BioCapital.
The Dish’s Weekly Biotechnology News Wrap Up – October 15, 2021
This week’s headlines include: J&J COVID-19 shot gets better boost from Moderna or Pfizer in NIH study, Merck seeks first U.S. authorization for COVID-19 pill, FDA drafts safety …
CAR-T Pioneer Carl June Will Lend Wisdom to Bioheng Biotech
June really broke out in 2012 when he saved the life of Emily Whitehead, a child suffering from relapsed acute lymphoblastic leukemia (ALL), with CD19 CAR-T.
Not for sale: Intellia isn't interested in a buyout, but CEO Leonard has an eye out for complementary tech
When Moderna’s CEO Stephane Bancel said he wanted to buy into gene editing, the chatter over the potential target flared to a roar. So you know we had to ask when we had Intellia CEO John ...
Industry vets launch Tentarix with $50M to develop antibody-based cancer-killing treatments
Industry vets from Eli Lilly, Amgen, Regeneron and more are ready for their next venture: launching biotech Tentarix Biotherapeutics with a $50 million series A fundraising to advance the ...
Two Bacterial Defense Systems Work to Defend against Bacteriophages
One bacterial defense system could be a useful biotech tool because the same DNA modifications that it recognizes appear throughout human genome, and change in cancer and neurodegenerative ...
Use of digital tools for clinical trials triples during pandemic; survey
Survey by Veeva Systems of pharma companies and CROs finds use of digital clinical trials technology triples during pandemic, with adoption set to rise even further in future